CompoAtlas

Omega-3 Super Concentrate

Natural health product licensed in Canada

Other names
Omega-3, Omega-3 EPA 400 DHA 200, Omega-3 High Potency, Omega-3 Total
Licence holder
WN Pharmaceuticals Ltd
NPN or DIN-HM
80003017
Status
Active licence
Licence date
14 March 2007
Revision date
22 March 2017
Form
Gélule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Huile de poisson

Source : anchovy, sardine or mackerel

Potency : 400 mg EPA

1,170 mgNot calculated
Huile de poisson

Source : anchovy, sardine or mackerel

Potency : 200 mg DHA

Not specifiedNot calculated
Huile de poisson

Source : anchovy, sardine or mackerel

Potency : 630 mg Omega-3 fatty acids

Not specifiedNot calculated

Non-medicinal ingredients

Gélatine, Glycérine, Tocopherols Excipient NF, Eau purifiée

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Gélule3 Tous les jours
AdultesNot specified1 Gélule5 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Omega-3 fatty acids help promotes cardiovascular health and brain function. Helps to reduce serum triglycerides/triacylglycerols. Helps to promote healthy mood balance. In conjunction with conventional therapy, helps to reduce the pain of rheumatoid arthritis in adults. Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps maintain/support cardiovascular health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80003017

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line